ChatDiagram
genetics · healthcare

Huntington disease autosomal dominant pedigree

A Huntington disease pedigree is a family diagram used to discuss a reported autosomal dominant pattern. It arranges relatives by generation and marks affected and unaffected family members, with the proband identified when relevant. This can make a multigenerational family history easier to understand in an educational setting. The visual is not a diagnosis and cannot determine whether an individual has a genetic variant. Ages of onset, symptoms, test results, and personal circumstances matter and should be discussed with an appropriate clinician or genetic counselor. Share any health information carefully and only with the people who need it for the intended discussion.

種類 系図規格 NSGC Pedigree Standardization (Bennett 2008)エンジン schematex-pedigree更新日 2026/9/24
Huntington Disease Family Pedigree
Drawing preview
依頼内容

“Draw a three-generation autosomal dominant Huntington disease pedigree with an affected father, an unaffected mother, two affected adult children, one unaffected adult child, and an affected female proband with an unaffected sibling.”

次はこちらAdd a child to the second affected adult child.Mark the affected father as deceased.
この図に含まれるもの

図の背後にある意思決定を読み解く。

01Use dominant mode

Match the chart header to the inheritance pattern.

02Trace affected relatives

Show the pattern in consecutive generations.

03Keep unaffected relatives

Make the contrast visible.

04Mark the proband

Identify the person whose history prompted the chart.

Use this as an educational autosomal-dominant example; individual risk and testing decisions require qualified review.

系図のテンプレートをすべて見る →

よくある質問

よくある質問

What is an autosomal dominant pedigree?

It is a family diagram used to show a reported dominant pattern across generations.

Why mark unaffected relatives?

They help make the documented family pattern clear without implying a diagnosis.

Can a family tree predict Huntington disease?

No. A pedigree summarizes family history; testing and risk assessment need qualified clinical guidance.